article thumbnail

Cannassure was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority

Cannabis Law Report

The patent will be in force until July 14, 2040. Currently the medical cannabis market is based on smoking inflorescence and oil for sub-lingual administration. The approval of the patent in Israel allows the company to file corresponding patent applications covering the innovative technology, in most countries of the world.